Robert S. Weinstein
#165,390
Most Influential Person Now
Robert S. Weinstein's AcademicInfluence.com Rankings
Robert S. Weinsteinphilosophy Degrees
Philosophy
#9716
World Rank
#13315
Historical Rank
Logic
#6683
World Rank
#8226
Historical Rank
Robert S. Weinsteinbiology Degrees
Biology
#13370
World Rank
#16915
Historical Rank
Endocrinology
#209
World Rank
#222
Historical Rank
Biochemistry
#2336
World Rank
#2485
Historical Rank
Download Badge
Philosophy Biology
Robert S. Weinstein's Degrees
- PhD Biochemistry Stanford University
- Doctorate Medicine Stanford University
Why Is Robert S. Weinstein Influential?
(Suggest an Edit or Addition)Robert S. Weinstein's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. (1998) (1645)
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research (2011) (1417)
- Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors Dissociation from Transcriptional Activity (2001) (1210)
- Matrix-embedded cells control osteoclast formation (2011) (1117)
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research (2010) (1063)
- Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. (1999) (1004)
- Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. (1999) (876)
- Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. (2004) (724)
- Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex Steroids* (2007) (592)
- Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines (1998) (568)
- Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. (2003) (559)
- Clinical practice. Glucocorticoid-induced bone disease. (2011) (496)
- Osteocyte Apoptosis Is Induced by Weightlessness in Mice and Precedes Osteoclast Recruitment and Bone Loss (2006) (466)
- Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. (2005) (450)
- Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. (2000) (422)
- New Developments in the Pathogenesis and Treatment of Steroid‐Induced Osteoporosis (1999) (396)
- Proteasomal Degradation of Runx2 Shortens Parathyroid Hormone-induced Anti-apoptotic Signaling in Osteoblasts (2003) (377)
- Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes (2008) (366)
- Alkaline Phosphatase Knock‐Out Mice Recapitulate the Metabolic and Skeletal Defects of Infantile Hypophosphatasia (1999) (366)
- Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. (1996) (350)
- Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. (2002) (347)
- Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. (2006) (346)
- Glucocorticoid-induced osteoporosis and osteonecrosis. (2012) (295)
- Glucocorticoid-induced osteonecrosis (2012) (288)
- Reversal of Bone Loss in Mice by Nongenotropic Signaling of Sex Steroids (2002) (273)
- FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. (2010) (252)
- Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice (2010) (246)
- Apoptosis and osteoporosis. (2000) (244)
- Glucocorticoids and Tumor Necrosis Factor α Increase Oxidative Stress and Suppress Wnt Protein Signaling in Osteoblasts* (2011) (238)
- The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. (2010) (234)
- Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. (1996) (219)
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research (2011) (215)
- Connexin 43 Is Required for the Anti‐Apoptotic Effect of Bisphosphonates on Osteocytes and Osteoblasts In Vivo (2008) (200)
- Estrogen receptor-α signaling in osteoblast progenitors stimulates cortical bone accrual. (2013) (195)
- Dose-Response Relationships for Alendronate Treatment in Osteoporotic Elderly Women (1997) (193)
- FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation (2014) (187)
- FOXOs attenuate bone formation by suppressing Wnt signaling. (2013) (187)
- Diminished rates of bone formation in normal black adults. (1988) (183)
- Perspective: Quantifying Osteoblast and Osteocyte Apoptosis: Challenges and Rewards (2007) (179)
- Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial. (1996) (173)
- Suppression of Autophagy in Osteocytes Mimics Skeletal Aging* (2013) (163)
- Decreased trabecular width and increased trabecular spacing contribute to bone loss with aging. (1987) (162)
- The Loss of Smad3 Results in a Lower Rate of Bone Formation and Osteopenia Through Dysregulation of Osteoblast Differentiation and Apoptosis (2001) (161)
- Reversal of bone loss in mice by nongenotropic signaling of sex steroids. (2003) (158)
- Efficacy and safety of a once‐yearly i.v. Infusion of zoledronic acid 5 mg versus a once‐weekly 70‐mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double‐blind, active‐controlled study (2010) (154)
- Osteocyte apoptosis. (2013) (153)
- Giant osteoclast formation and long-term oral bisphosphonate therapy. (2009) (152)
- Glucocorticoid-Induced Osteoporosis (2004) (148)
- Application of fractal geometry techniques to the study of trabecular bone. (1993) (147)
- Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. (1984) (147)
- Multiple immunoreactive forms of osteocalcin in uremic serum. (1986) (137)
- Spectroscopic markers of bone quality in alendronate-treated postmenopausal women (2009) (131)
- Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. (2009) (128)
- Bone histomorphometry in vitamin D-deficient rats infused with calcium and phosphorus. (1984) (125)
- Issues in modern bone histomorphometry. (2011) (125)
- The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage. (1997) (125)
- Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity. (2010) (117)
- Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice. (2010) (117)
- Estrogens Attenuate Oxidative Stress and the Differentiation and Apoptosis of Osteoblasts by DNA-Binding-Independent Actions of the ERα (2009) (117)
- Old age causes de novo intracortical bone remodeling and porosity in mice. (2017) (114)
- Recognition and management of poisoning with beta-adrenergic blocking agents. (1984) (110)
- Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration (2010) (108)
- Chromosomal Mapping of Osteopenia‐Associated Quantitative Trait Loci Using Closely Related Mouse Strains (2000) (104)
- Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study (2004) (102)
- Quantification of Vitamin D Receptor mRNA by Competitive Polymerase Chain Reaction in PBMC: Lack of Correspondence with Common Allelic Variants (1997) (101)
- Fractal geometry and vertebral compression fractures (1994) (100)
- Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency. (2014) (100)
- Hypophosphatasia: Clinicopathologic Comparison of the Infantile, Childhood, and Adult Forms (1984) (98)
- Long‐Term Aminobisphosphonate Treatment of Fibrous Dysplasia: Spectacular Increase in Bone Density (1997) (85)
- Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappaB ligand gene reduces bone remodeling and increases bone mass. (2008) (83)
- Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women (2003) (80)
- The skeletal effects of glucocorticoid excess override those of orchidectomy in mice. (2004) (73)
- Erratum: Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research (Journal of Bone and Mineral Research (2010) 25 (2267-2294)) (2011) (72)
- Continuous Elevation of PTH Increases the Number of Osteoblasts via Both Osteoclast-Dependent and -Independent Mechanisms (2010) (70)
- IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. (2005) (70)
- True Strength (2000) (68)
- The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and Osteoclasts (2015) (68)
- Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers. (1997) (67)
- Dysapoptosis of Osteoblasts and Osteocytes Increases Cancellous Bone Formation But Exaggerates Cortical Porosity With Age (2014) (65)
- Differences in mineral metabolism among nonhuman primates receiving diets with only vitamin D3 or only vitamin D2. (1989) (64)
- The Pathophysiological Sequence of Glucocorticoid-Induced Osteonecrosis of the Femoral Head in Male Mice (2017) (62)
- Beta blocker overdose with propranolol and with atenolol. (1985) (61)
- Glucocorticoid Excess During Adolescence Leads to a Major Persistent Deficit in Bone Mass and an Increase in Central Body Fat (2001) (58)
- Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass. (2013) (58)
- Heterogeneity of adult hypophosphatasia. Report of severe and mild cases. (1981) (53)
- Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone. (2015) (44)
- Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice. (2011) (41)
- Biologic and therapeutic determinants of bone mineral density in multiple myeloma. (1998) (38)
- Giant osteoclasts after long-term bisphosphonate therapy: diagnostic challenges (2009) (36)
- Oxidation-specific epitopes restrain bone formation (2018) (33)
- Deletion of Rac in Mature Osteoclasts Causes Osteopetrosis, an Age‐Dependent Change in Osteoclast Number, and a Reduced Number of Osteoblasts In Vivo (2016) (31)
- Bone involvement in multiple myeloma. (1992) (31)
- Ancient bone disease in a Peruvian mummy revealed by quantitative skeletal histomorphometry (1981) (30)
- Systemic bone disease in patients with mandibular atrophy. (1982) (29)
- Recurrent hypothermia, hypersomnolence, central sleep apnea, hypodipsia, hypernatremia, hypothyroidism, hyperprolactinemia and growth hormone deficiency in a boy--treatment with clomipramine. (1986) (28)
- Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice. (2016) (28)
- The RANKL distal control region is required for the increase in RANKL expression, but not the bone loss, associated with hyperparathyroidism or lactation in adult mice. (2012) (23)
- Parathyroid carcinoma associated with polycythemia vera. (1991) (20)
- Is long-term glucocorticoid therapy associated with a high prevalence of asymptomatic vertebral fractures? (2007) (18)
- Fractal geometry applied to the architecture of cancellous bone biopsy specimens (1992) (15)
- Fifty-Year Follow-up of Hypophosphatasia (1981) (14)
- Parathyroid hormone and 25-hydroxycholecalciferol levels in hypercalcemia of acute renal failure. (1980) (14)
- Decreased mineralization in hemodialysis patients after subtotal parathyroidectomy (2006) (14)
- Apoptosis of Bone Cells (2008) (12)
- Correlates of amylase and lipase levels in chronic dialysis patients. (1988) (12)
- A novel locus on the X chromosome regulates post-maturity bone density changes in mice. (2007) (11)
- Immunoreactive Calcitonin in Pheochromocytomas 1 (1980) (11)
- Apoptosis in glucocorticoid-induced bone disease (2005) (9)
- Hypercalcemic hyperparathyroidism and hypophosphatemic osteomalacia complicating neurofibromatosis (1990) (9)
- Fifty-year follow-up of hypophosphatasia. (1981) (9)
- Focal mineralization defect during disodium etidronate treatment of calcinosis (1982) (9)
- Qualitative bone defect in uremic osteosclerosis. (1982) (8)
- GLUCOCORTICOIDS AND TUMOR NECROSIS FACTOR (TNF) α INCREASE OXIDATIVE STRESS AND SUPPRESS WNT SIGNALING IN OSTEOBLASTS (2011) (8)
- Response to Windahl et al. (2006) (8)
- CHAPTER 44 – Glucocorticoid-Induced Osteoporosis (2008) (8)
- Parathyroid hormone and corticosteroid-induced osteoporosis (1998) (7)
- Chapter 58. Glucocorticoid‐Induced Osteoporosis (2009) (7)
- Case report: hypercalcemia in acute myeloblastic leukemia is caused by osteoclast activation. (1993) (7)
- Dual-energy X-ray absorptiometry versus single photon absorptiometry of the radius (1991) (6)
- Hypercalcemia due to hard water used for home hemodialysis. (1992) (6)
- The Histological Heterogeneity of Osteopenia in the Middle-Aged and Elderly Patient (1983) (6)
- Chronic erythroid hyperplasia and accelerated bone turnover. (1983) (6)
- Should analysts love their patients (1986) (5)
- Coalescing Expansile Skeletal Disease: Delineation Of An Extraordinary Osteopathy Involving The IFITM5 Mutation Of Osteogenesis Imperfecta Type V. (2020) (5)
- The pathogenesis of glucocorticoid-induced osteoporosis (2000) (5)
- Sonographic findings in Bartholin's gland hamartoma (1998) (4)
- 11[beta]-HSD: Guardian or gate crasher? (2005) (4)
- Pseudofractures in the absence of osteomalacia (1982) (4)
- Chapter 49 – Glucocorticoid-Induced Osteoporosis (2013) (4)
- What Heals in Psychoanalysis? (2007) (4)
- Treating panic disorder. (1997) (3)
- On Love, AIDS and Emotional Contact in Psychotherapy (2001) (2)
- Hypercalcemia and Vitamin D Metabolism-Reply (1981) (2)
- The Interaction of Vocal Context and Lexical Predictability (1965) (2)
- Needle bone biopsy: how, when, why. (1981) (2)
- Hypercalcemia and nephrolithiasis provoked by serum phosphorus reduction in a patient with chronic renal failure and sarcoidosis. (1983) (2)
- Iron replacement ameliorates hypophosphatemia in autosomal dominant hypophosphatemic rickets: A review of the role of iron. (2019) (2)
- Issues in modern bone histomorphometry: Presented at the Fortieth International IBMS Sun Valley Skeletal Tissue Biology Workshop; August 1, 2010 (2011) (2)
- Effects of Oral Base Therapy on Serum Ionized Calcium, Phosphorus and Parathyroid Hormone in Chronic Hemodialysis Patients (1989) (2)
- Human Bone Biopsy (2003) (1)
- Glucocorticoids, aging and bone hydration: New insights into qualitative aspects of bone strength (2007) (1)
- Clinical management of osteoporosis. (1994) (1)
- Erratum: “Application of fractal geometry techniques to the study of trabecular bone” [Med. Phys. 20 , 1611-1619 (1993)] (1994) (1)
- Submitted, Not Presented: Inflammatory Bowel Disease (2016) (1)
- 252 – Osteomalacia and Rickets (2012) (1)
- Skeletal benefits are maintained through 7 years of alendronate treatment (2002) (1)
- Estrogens on Cancellous But Not Cortical Bone The Estrogen Receptor-{alpha} in Osteoclasts Mediates the Protective Effects of (2010) (1)
- Idiopathic osteoporosis: Is the osteoblast to blame? [4] (multiple letters) (1998) (1)
- OR30-6 Parathyroid Carcinoma as a Complication of Inadequately Treated Pseudohypoparathyroidism (2019) (0)
- Oxidation-specific epitopes restrain bone formation (2018) (0)
- Glucocorticoid-induced osteoporosis and Cushing’s syndrome (2021) (0)
- Procedes de detection d'agents regulant l'apoptose destines a la therapie anabolisante osseuse et utilisations de tels agents (1999) (0)
- Contributors (2012) (0)
- Poster abstracts from the 34 th Meeting of the International Sun Valley Workshop on Skeletal Tissue Biology 1-4 August 2004 , Sun Valley , Idaho , USA Program Chairman : (2004) (0)
- Letter to the Editor Further Study of the Therapy for Fibrous Dysplasia Is Necessary Reply Wait for Study or Treat? Treat (1997) (0)
- Risk Factors for Metabolic Bone Disease in IBD: 2458 (2016) (0)
- 176 Management of Neonates with a Prenatal Ultrasound Diagnosis of an Obstructing Cervical Mass (1995) (0)
- Osteocyte function and glucocorticoids (2009) (0)
- Tu1882 Metabolic Bone Disease Associated With Inflammatory Bowel Disease is Due to Increased Bone Resorption and Correlates With IL-1β Activity Over Time (2016) (0)
- 58. Glucocorticoid-Induced Bone Disease (2013) (0)
- Molecular Basis of Metastasis (2009) (0)
- List of contributors (2021) (0)
- Panic disorder. (1995) (0)
- Idiopathic osteoporosis: is the osteoblast to blame? (1998) (0)
- Subject Index, Vol. 33, 1983 (1983) (0)
- Contents, Vol. 33, 1983 (1981) (0)
- IL-1 Beta Plays a Crucial Role in the Altered Bone Metabolism of Inflammatory Bowel Disease (2017) (0)
- Age-related Influence of Colonization by an AIEC Pathobiont on the Severity of DSS-induced Colitis (2017) (0)
- Year 2000 Health Objectives (1990) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert S. Weinstein?
Robert S. Weinstein is affiliated with the following schools:
